Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

InternetNews January 16, 2008	Oracle Prevails in BEA Bid Oracle won a three-month-long campaign to buy BEA Systems by raising its bid for the business software maker by 14 percent to $8.5 billion.
The Motley Fool November 16, 2007 Tom Taulli	Beleaguered BEA Middleware developer BEA turns in a good quarter, despite juggling an options investigation and a hostile takeover attempt from Oracle.
The Motley Fool October 15, 2007 Anders Bylund	BEA Plays a Fool's Game A multi-billion-dollar bidding war is about to start. Or is it? Buying BEA stock today is a gamble that the company's price tag will grow before an eventual sale. A sensible investor might take the gains here and go look for a safer bet.
InternetNews November 14, 2007 Larry Barrett	BEA to File Past-Due Financial Reports BEA Systems will try to save its Nasdaq listing and protect itself from future proxy fights with shareholders.
The Motley Fool September 18, 2007 Tom Taulli	Icahn Beats Up BEA Why has the legendary corporate activist set his sights on the struggling software developer? Investors, take note.
InternetNews January 16, 2008 Larry Barrett	Oracle Digs Deep to Snare BEA After more than three months of posturing, Oracle finally agrees to pay more than $8.5 billion for the BEA.
InternetNews October 12, 2007 Larry Barrett	Oracle Raises Stakes With BEA Offer Oracle is looking to trump SAP, making a $6.7 billion bid for BEA less than a week after its rival paid a similarly hefty sum for Business Objects.
The Motley Fool September 1, 2009 Rick Aristotle Munarriz	Icahn Handles the Truth at Yahoo! Carl Icahn has sold shares of struggling online giant Yahoo! in each of the past three trading days, enough to take his stake below 5%.
The Motley Fool October 18, 2007 Tim Beyers	Icahn Is Crazy for Snubbing Oracle A bid for BEA is one thing. But a bidding war? No way. Investors, take note.
The Motley Fool October 14, 2011 Travis Hoium	Navistar International Shares Popped: What You Need to Know Shares of Navistar International drove as much as 16% higher today before dropping to a more modest gain of 8% mid-day.
The Motley Fool June 4, 2009 Brian Orelli	Ignore Icahn's Hoopla Carl Icahn and his fights with management at Biogen's Idec make for entertaining news coverage, but investors shouldn't spend too much time analyzing how the antics are going to affect the share price.
The Motley Fool July 23, 2008 Rick Aristotle Munarriz	Icahn's Spotty Track Record Carl Icahn and Yahoo! have made nice, in advance of next week's meeting, but will the peace last? Or is the current calm just the eye of the hurricane?
The Motley Fool February 23, 2010 Brian Orelli	Icahn Puts His Proxy Fight Where His Money Is How patient will Carl Icahn be with Genzyme's turnaround plan? That's the $270 million question -- the value of Icahn's shares, based on his holdings at the end of the year.
The Motley Fool February 17, 2010 Anders Bylund	Who Is Icahn Selling To Now? Lionsgate is looking to buy the Miramax studio from Walt Disney in what looks like a good stylistic match. Will Carl Icahn turn the tables on that deal and coax a bid out of Disney?
InternetNews October 26, 2007 Christopher Saunders	BEA Bites Back in Oracle Bid BEA Systems shrugs off Oracle's lambasting over its counterproposal.
The Motley Fool June 22, 2011	Here's What Carl Icahn Bought and Sold Last Quarter A look under the hood at what Carl Icahn was up to in the first three months of 2011.
The Motley Fool November 18, 2008 Brian Orelli	Icahn's Next Biotech Adventure With ImClone done, he's got his eye focused elsewhere.
The Motley Fool September 15, 2008 Brian Orelli	Side Effects Don't Scare Icahn Billionaire investor Carl Icahn upped his stake in the drug company by almost 50% and now owns 7.3% of the company.
The Motley Fool January 16, 2008 Tim Beyers	Oracle Caves Oracle agrees to acquire middleware maker BEA for $8.5 billion.
The Motley Fool August 5, 2008 Brian Lawler	An ImClone Deal Will Get Done Despite his tough talk, Icahn will likely complete a buyout of ImClone.
BusinessWeek March 5, 2007 Ronald Grover	Just Don't Call Him A Raider Carl Icahn, who now styles himself a shareholder activist, prepares for battle with Motorola.
BusinessWeek March 6, 2006 Ronald Grover	Carl Icahn: Still An Improbable Robin Hood Carl Icahn is out to recast himself as the hedge fund investor's champion. That image has its critics.
The Motley Fool January 29, 2010 Brian Orelli	Icahn Back to Batter Biogen The old guy has tenacity.
The Motley Fool June 11, 2008 Brian Lawler	He Said, Biogen Said Pharmaceutical Biogen Idec's battle with Carl Icahn is coming to a head.
InternetNews October 15, 2007 Larry Barrett	Why Oracle's Tops in Takeovers Industry watchers think BEA's days are numbered: Larry Ellison and Oracle have spent years and billions mastering the art of the takeover.
InternetNews January 30, 2007 Ed Sutherland	Icahn Has Motorola in His Sites News Wall Street trader Carl Icahn wants a spot on Motorola's board sent tongues wagging and stock prices up.
InternetNews October 12, 2007 Paul Shread	Oracle Ignites Tech Stocks Oracle's hostile takeover bid for BEA made traders forget about interest rates and valuations for a day... The chip sector notched its first gain in three days... Blue Nile fell on a Citigroup downgrade... etc.
The Motley Fool March 23, 2010 Brian Orelli	Icahn and Biogen Kiss and Make Up He gets one more seat on the board, so what's next?
National Real Estate Investor December 4, 2002 Parke Chapman	Investor now holds 6.9% stake in Insignia Carl Icahn now holds a 6.9% stake in real estate operator Insignia Financial Group Inc.
InternetNews November 16, 2007 Larry Barrett	Oracle Content Without BEA Oracle's CEO Larry Ellison made it clear the company has no intention to sweeten its original offer for BEA Systems.
InternetNews July 26, 2005 Sean Michael Kerner	IDC: IBM Brings up the Middle Big Blue led the application deployment software market with $7 billion in middleware revenue last year. BEA and Oracle also had strong showings.
The Motley Fool May 29, 2008 Brian Lawler	Icahn Girds for Biogen Battle The activist investor officially launches his bid to usurp Biogen's board of directors.
InternetNews October 29, 2007 Sean Gallagher	Time Runs Out on Oracle Bid For BEA Oracle's bid for BEA expired over the weekend, leaving many to speculate about BEA's future. And at least one of BEA's largest stockholders is on the warpath.
BusinessWeek August 11, 2003 Christopher Palmeri	Global Crossing: A Matter of National Security? Carl Icahn is lobbying to keep it in American hands -- his
The Motley Fool January 29, 2008 Brian Lawler	Icahn Tries to Board USS Biogen Carl Icahn and the funds that he runs announce that they will try to get elected to three seats on the board of directors at Biogen Idec.
InternetNews October 23, 2007 Sean Gallagher	Oracle Threatens to Walk Away from BEA Deal President Charles Phillips says Oracle has no interest in a long, drawn-out process to acquire BEA.
BusinessWeek April 9, 2007 Roben Farzad	Activist Investors Not Welcome Activist hedge fund manager Carl C. Icahn's interference at Motorola stands in the way of its mission.
The Motley Fool December 21, 2010 Toby Shute	Chesapeake Energy in the Crosshairs What's this activist investor got planned for the energy titan?
The Motley Fool June 10, 2010 Brian Orelli	Cancel the Clowns: Icahn Avoids a Circus The billionaire investor backs down from a fight. He withdrew his slate of candidates to join Genzyme's board yesterday.
The Motley Fool February 8, 2005 Tom Taulli	Retro Raider Strikes Again Carl Icahn has been very busy lately -- and his most recent prey is cardboard packaging manufacturer Temple-Inland. The stock closed unchanged yesterday at $75.75. It had surged 16% when his interest in the stock became public.
InternetNews June 23, 2004 Michael Singer	Ellison 'Green' with Envy Analysts debate whether Oracle is after SAP's high-end or Microsoft's mid-tier.
InternetNews April 19, 2006 Clint Boulton	As Goes IBM Software... IBM delivers solid profits for the first quarter. Merrill Lynch gauges the impact of the software division's results.
BusinessWeek November 29, 2004 Jim Kerstetter	BEA: A Little Down In The Valley Not long ago the software maker BEA Systems Inc. (BEAS ) seemed unstoppable. Now rivals are gaining ground. Rather than reassessing his strategies in the face of widespread evidence that they're not working, CEO Alfred Chuang is determined to stay the course.
The Motley Fool May 13, 2009 Brian Orelli	Icahn's an Energizer Pit Bull He keeps going and doesn't let go.
The Motley Fool March 30, 2011 Anders Bylund	Mentor Could Use Some Guidance Is the company looking to preserve shareholder interest or management paychecks?
The Motley Fool September 24, 2008 Brian Lawler	Bristol-Myers Puts Icahn and ImClone to the Test Despite trying to project different intentions last week, pharma giant Bristol-Myers Squibb raised its bid for ImClone Systems.
The Motley Fool January 30, 2009 Brian Orelli	Icahn's Next Target Activist investor Carl Icahn has decided to nominate a slate of five directors for the board of Amylin Pharmaceuticals, of which he owns 8.3%.
The Motley Fool October 4, 2006 Brian Lawler	Unwelcome Guests at ImClone ImClone's board of directors votes against Carl Icahn's proposed removal of six company directors. Short-term shareholders that are able to cash out with Icahn, will possibly have a nice gain to take home.
The Motley Fool April 6, 2011	Here's What Icahn Capital Bought and Sold Last Quarter Carl Icahn is CEO of Icahn Capital, which is a privately owned hedge fund sponsor that invests in small- and medium-sized companies having undervalued share prices. Let's take a look at their recent moves.
The Motley Fool September 21, 2006 Brian Lawler	ImClone's Board Shakeup A new face in the boardroom heralds change for the troubled company. Shareholders yesterday elected notorious corporate raider Carl Icahn to the company's board of directors.